Angene

 

Angene is pledged to providing quality chemicals for use in research and development and commercial manufacturing. Angenes offers over 100,000 products including lab reagents, Building blocks,intermediates, bulk commodities, agro-chemicals, natural ingredients and active pharmaceutical ingredients (APIs). In addition to the 100,000+ products, Angene offers custom synthesis of chemicals that are not commercially available.

 

 
 
 
 
SARS-CoV-2 - Therapeutic Candidates for Research and Development

SARS-CoV-2 - Therapeutic Candidates for Research and Development

 

SARS-CoV-2, the cause of the COVID-19 epidemic currently affecting all countries in the world, belongs to the genus of betacoronaviruses, which also includes the SARS CoV (2003) and the MERS CoV (2012). 
At present, no vaccine or treatment is available to address the COVID-19 pandemic. The SARS-CoV-2 has been the subject of numerous studies that have provided information on its structure, size and protein composition, but there is still room for improvement in understanding its mechanism of interaction with the cells it infects. The current challenge, pending the development of an effective vaccine, is to develop a treatment for the disease that accompanies SARS-CoV-2 infection. Numerous clinical studies are underway or will begin to test various therapeutic candidates for COVID-19.
We offer a wide range of molecules from these therapeutic candidates to support the research and development of a treatment for CoV-2-SARS and COVID-19.